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ABSTRACT 
 
MEASURING MUSCLE FATIGUE WITH ACCELEROMETER-BASED 
MECHANOMYOGRAPHY: A PILOT STUDY 
 
 
By  
 
Erica Armstrong, BS 
 
 
 
Objectives: Patients admitted to the intensive care unit (ICU) are at a higher risk for developing 
muscle weakness, which is associated with prolonged recovery, poor quality of life, and greater 
rates of mortality. This study mimicked changes we expect to see in patients with clinical 
weakness by manipulating blood flow to determine whether mechanomyography is sensitive 
enough to detect the expected change.   Methods: Recreationally active individuals (n = 10) 
were recruited for this study. Stimulating electrodes and an accelerometer were placed on the 
muscle belly of the extensor carpi radialis and tibialis anterior. Muscles were stimulated at a rate 
of 2, 4, and 6, Hz for three minutes each at 60mA. Two trials were performed for each muscle, 
one with and one without occluded muscle blood flow. Results: Accelerations (muscle twitch 
height) decreased in the extensor carpi radialis (0.944 ± 0.188g, p < 0.001) and tibialis anterior 
(0.515 ± 0.198g, p = 0.018) when blood flow was occluded compared to the normal blood flow 
trials. The normal blood flow trial accelerations were higher in the extensor carpi radialis 
compared to the tibialis anterior (1.173 ± 0.242g, p < 0.001). After data were normalized these 
differences were no longer significant. Conclusions: The results of this study indicate 
accelerometer based mechanomyography can differentiate between fatigue associated with 
impaired blood flow to the muscle. Future research should examine whether accelerometer based 
mechanomyography can distinguish muscle quality in clinically relevant populations.  
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CHAPTER I 
 
Introduction 
 
Neuromuscular weakness often results from extended periods of critical illness or injury. 
This weakness, called intensive care unit acquired weakness (ICUAW), is associated with 
prolonged periods of recovery and a decreased quality of life (Sidiras et al., 2019). Patients with 
ICUAW have higher rates of functional impairments after discharge compared to those who do 
not have ICUAW, with as many as 80% of patients having functional impairments for up to five 
years after discharge (Jolley et al., 2016). These patients also have greater rates of mortality pre 
and post ICU discharge (Hermans et al., 2014; Wieske et al., 2015). 
Early diagnosis is thought to be crucial in the treatment of ICUAW (Wieske et al., 2014; 
Novak et al., 2009; Latronico et al., 2009). However, the tests that are currently available have 
multiple drawbacks and limitations that prevent their use in patients early in the disease process. 
Nerve conduction studies detect muscle weakness by calculating the speed of the electrical 
impulse in motor nerves via electrodes placed on the skin. However, nerve conduction studies do 
not assess the muscle itself; instead, they provide information on the number of functioning 
nerve fibers, as well as nerve conduction velocity (Kane & Oware, 2012; Tavee, 2019). Research 
has also indicated that this test lacks standard diagnostic criteria, and is not a definitive test (Fan 
et al., 2014). Nerve conduction studies alone cannot determine the cause of the illness and must 
be used in conjunction with other diagnostic tests (Camdessanché et al., 2006). These tests also 
require a high level of patient cooperation, as well as medical personnel expertise (Fuller, 2005; 
Jolley et al., 2016; Kress & Hall, 2014). Nerve conduction studies are expensive and can be 
painful for the patient (Fuller, 2005). The ICU patient has an increased risk for injury due to 
movement during the test, as well as an increased risk for developing edema due to the needle 
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electrodes used (Morris & Trinder, 2002; Schweickert & Hall, 2007; Trojaborg, 2006). 
Subsequent attempts have been made to use surface electrodes instead of needles, but findings 
indicate these electrodes are not accurate, as skin resistance interferes with the calculated nerve 
conduction velocity (Evangelopoulos et al., 2017; Kural et al., 2016).  
Another muscle function test is a clinical strength assessment. These strength assessments 
can be performed via one of two avenues: a manual muscle test (Medical Research Council, 
1976) or dynamometry. In a manual muscle test, muscle groups of the upper and lower 
extremities of the patient are measured against the medical examiner’s resistance. The patient’s 
strength is rated on a zero to five scale, with zero indicating no muscle activation and five 
indicating full range of motion and activation against the examiner’s resistance (Bohannon, 
2019; Ciesla et al., 2011; Naqvi & Sherman, 2019). If patient effort is reduced, the test allows the 
patient to perform the test with gravity eliminated. Notwithstanding, testing outcomes vary due 
to subjective scoring methods and poor interobserver agreement (Hough et al., 2011). Manual 
muscle testing does not accommodate patients who suffer from painful musculoskeletal 
conditions (Naqvi & Sherman, 2019). Notably, however, is that this test does not quantify 
muscle strength, but suggests a strength level (Naqvi & Sherman, 2019). Dynamometry, on the 
other hand, quantifies muscle strength through a dynamometer – a device that records force by 
loading compression of a spring (Samosawala et al., 2016). Although dynamometry is more 
objective than manual muscle testing, it is still subject to various drawbacks. For instance, it does 
not pertain to all clinical conditions; reliability can vary depending on disease states (O’Shea et 
al., 2007). Dynamometry results also vary depending on the type of dynamometer used and the 
specific muscle tested (Mafi et al., 2012). Age and/or gender may play a role in dynamometry 
outcomes, but as to how or what extent of a role they play is unclear (Davies et al., 1984; 
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Wadsworth et al., 1992). Manual muscle testing and dynamometry additionally require that the 
patient be awake, alert, and cooperative (Hough et al., 2011; Kress & Hall, 2014; Schweickert & 
Hall, 2007). This is not feasible in a large number of ICU patients, as many receive sedatives 
during their ICU length of stay, and/or may be comatose or delirious (Ely et al., 2004; Hough & 
Herridge, 2012).  
 Other researchers have suggested that measuring muscle weakness is futile, as treatment 
and interventions are not being implemented despite attempts to diagnose weakness (Morris & 
Trinder, 2002). In cases where treatments are implemented, they are not standardized, and 
outcomes are varied (Koukourikos et al., 2014). While some research has suggested limiting 
medications that may contribute to muscle weakness and loss – such as corticosteroids, 
neuromuscular blockers, and aminoglycosides – other research has suggested limiting parenteral 
nutrition (Falagas & Kasiakou, 2006; Koukourikos et al., 2014; Nanas et al., 2008; Rich & 
Pinter, 2003; Yang et al., 2018). Conversely, prior research has shown by and large that early 
mobilization plays a major role in preventing muscle atrophy (Anekwe et al., 2019; Hashem et 
al., 2016; Lynch et al., 2007; Wischmeyer & San-Millan, 2015). Walking, and even small 
movements, such as positioning the patient in the bed or chair, are associated with positive 
outcomes (Jang et al., 2019; Koukourikos et al., 2014).  
Failure to implement these treatments for patients with ICUAW may in part be a result of 
a lack of appropriate, valid, and reliable diagnostic tests. This ultimately highlights the need for a 
test that is objective, can be easily administered by the medical practitioner, and poses little risk 
and discomfort to the patient, regardless of the patient’s state of consciousness.   
 Recent research has examined the use of accelerometer mechanomyography to measure 
muscle fatigue during intermittent contractions, and thereby muscle function (Willingham & 
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McCully, 2017). Although a muscle may contract, the force produced by said contraction varies 
according to the strength of the electrical signal that originates within the central nervous system 
(CNS); as the signal diminishes – either by reducing the firing frequency of the neurons or 
reducing the number of neurons that are firing – the force of the contraction decreases 
(Shinohara & Søgaard, 2006). However, muscle contraction and endurance of contraction is also 
dependent upon the structure of the muscle fiber itself (Frontera & Ochala, 2015). A muscle that 
is oxygen deficient will be unable to maintain the resynthesis of  adenosine triphosphate (ATP), 
the molecular unit of energy, over an extended period of time. Lack of ATP – and a lowered 
ATP/ADP ratio (adenosine diphosphate, or ADP, is an organic compound created when ATP 
loses a phosphate group)  – is associated with an inability to maintain the force of a muscle 
contraction. The more rapidly the blood supply (and therefore oxygen) diminishes, and the more 
metabolites (such as inorganic phosphate) accumulate, the faster the muscle fatigues (Bigland-
Ritchie & Woods, 1984). Ultimately, a muscle that fails to sustain the force of a contraction is 
indicative of fatigue (Tachi et al., 2004; Tarata, 2003). 
When paired with electrical stimulation, an accelerometer can detect the amount of 
muscle acceleration, and therefore muscle force. The force of a contraction is the result of 
acceleration upon a particular mass. The overall force of muscle contraction is generated by the 
force per cross-bridge formed (discussed in detail below) (Grazi, 2010).  As the velocity and 
length of a muscle change, it affects the acceleration of the muscle, which in turn affects the 
force generated by the muscle (Roberts & Marsh, 2003). By measuring the acceleration of the 
muscle, it may be possible to distinguish patterns of fatigue in the muscle. Theoretically, by 
measuring rates of fatigue, functional impairments in the muscle can be determined. 
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Furthermore, accelerometer mechanomyography is preferred because it is noninvasive, 
inexpensive, and does not require that the patient be alert or conscious (Ibitoye et al., 2014).   
 In order to test accelerometer mechanomyography in a population with true ICUAW, this 
test must first be done on healthy individuals so the test can be validated. As such, healthy, 
recreationally active athletes were recruited for this study. Clinical muscle weakness was 
simulated in each participant by reducing the amount of oxygen (i.e., perfusion) to muscles using 
a tourniquet. 
Purpose of Study  
 The purpose of this study was to determine whether accelerometer-based 
mechanomyography can detect functional changes in the muscle (i.e., levels of muscle fatigue) 
by discriminating between conditions of blood flow to the muscle. To date, most tests measuring 
muscle atrophy and fatigue fail to provide objective data or are unable to be conducted in 
patients with severe critical illness, most often due to neurocognitive impairments (Ely et al., 
2004). By measuring muscle acceleration, we sought to identify a significant increase in fatigue 
during the occluded blood flow trial.   
The following hypotheses were considered in the current project: 
1. Poorly perfused muscles will have decreased muscle twitch accelerations compared to 
adequately perfused muscles.  
2. Decreases in poorly perfused muscle twitch accelerations will appear at lower stimulation 
frequencies compared to adequately perfused muscles.  
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Significance of Study 
By evaluating the use of accelerometer-based mechanomyography, this study hopes to 
provide evidence that this procedure could detect functional changes that mimic what we would 
expect in an ICU patient with clinical weakness. This study will advance clinical work in the 
field of respiratory care, physical therapy, and other medical practice by identifying those who 
are most at risk for muscle atrophy and ICUAW. According to the American Thoracic Society 
(Fan et al., 2014), there is no current, standard criteria for diagnosis of ICUAW, and current 
results are inconclusive and subjective. Consequently, there is a clear need for a new 
methodology used to assess muscle weakness in ICU patients.  
Definition of Terms 
Accelerometer: a device that records muscle acceleration (twitch) on three axes of motion (x, y, 
z).  
Adenosine Triphosphate (ATP): the primary organic chemical responsible for providing energy 
to living cells. It is often referred to as the “molecular unit of currency” in regard to cellular 
energy.  
Clinical Strength Assessment: a diagnostic test that evaluates muscle force production. See 
Manual Muscle Test and Dynamometry.  
Dynamometry: a diagnostic test in which patient strength is measured by the force of loading via 
tension or compression.   
Electromyography: the process of measuring electrical activity in muscle tissue via electrodes 
placed on the skin.  
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g: gravitational force equivalent, colloquially known as g-force. A measurement of the force per 
unit mass due to gravity at the earth’s surface.  
Intensive Unit Care Acquired Weakness (ICUAW): neuromuscular impairment acquired in the 
intensive care unit as a result of polyneuropathy, myopathy, and/or muscle atrophy. Commonly 
seen in patients who have bed sores, inadequate physical activity, and who are mechanically 
ventilated for 21 days or longer (MacIntyre et al., 2005).  
Manual Muscle Test: a diagnostic test in which muscles of the upper and lower extremities are 
measured against a medical examiner’s resistance. Patient strength is rated on a zero to five 
scale, with zero indicating no muscle activation and five indicating full range of motion and 
activation against the examiner’s resistance.  
Mechanomyography: the process of detecting muscle vibration, or twitch, by the summation of 
electrical signals generated by motor units near electrodes via a device that measures 
acceleration. 
Motor Unit: a motor neuron and the muscle fibers it innervates. Muscle force is dependent upon 
both the firing rate of the motor unit and the number of motor units that are firing.  
Nerve Conduction Study: a diagnostic test that evaluates nerve function and velocity. Sensory or 
motor nerves are stimulated by an electrical impulse via electrode patches attached to the skin.  
Perfusion: the passage of blood through the cardiovascular or lymphatic system, delivered to an 
organ or tissue. Malperfusion (poor perfusion) can lead to ischemia.  
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Delimitations 
 This study includes a population that is involved in moderate to high levels of physical 
activity. Although there were attempts to mimic the clinical population, results cannot be 
generalized to other populations. This pilot study is the first in a series of many that will look at 
muscle function in different populations; tests should not be used on critically ill populations 
until indications are warranted. These limitations are beyond the control of the researcher.  
Assumptions 
1. Each participant tested meets criteria for the operational terms ‘healthy’ and ‘recreational 
athlete’.  
2. Lack of distal pulse is a valid indicator of limited perfusion to the muscle. 
CHAPTER II 
Review of Literature 
In the United States alone, approximately 4 million individuals are admitted to the 
intensive care unit (ICU) each year, with mortality rates estimated at 8-19% (Mukhopadhyay et 
al., 2014). Among those who survive, approximately 25% will experience some form of ICUAW 
(Angus et al., 1996; Fan et al., 2014). ICUAW is associated with numerous adverse outcomes, 
including increased length of hospital stay, prolonged mechanical ventilation, and increased rates 
of mortality both before and after ICU discharge (Hermans & Van den Berghe, 2015; Sharshar et 
al., 2009). Given these high rates, it becomes imperative that medical professionals seek ways to 
combat muscle weakness and therefore avoid adverse patient outcomes. In order to provide 
effective, adequate care, a comprehensive understanding of skeletal muscle anatomy and 
physiology is needed.  
Skeletal Muscle Anatomy 
 Skeletal muscle comprises approximately 40% of body weight and is responsible for 
producing a variety of voluntary movements, including explosive movements such as running or 
jumping (Frontera & Ochala, 2015; Westerblad et al., 2010).  Due to the nature of such 
movements, skeletal muscle has evolved in order to rapidly increase its energy expenditure 
compared to cardiac muscle (Mukund & Subramaniam, 2020; Westerblad et al., 2010). Yet 
unlike cardiac muscle, skeletal muscle is subject to fatigue, defined as any reversible decline in 
muscle performance due to muscle activity (Allen et al., 2008). Fatigue can be measured by a 
decrease in muscle force, as well as reduced velocity of muscle contraction (Allen et al., 2008). 
Closer examination of the cellular structure and molecular changes that occur in skeletal muscle 
reveal how force is produced (how fatigue occurs within the muscle is discussed later). 
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 Like most systems within the body, muscle is organized in a hierarchical fashion. The 
muscle fiber, (known also as a myofiber or muscle cell), is a multinucleated cell, with nuclei 
evenly distributed throughout the periphery of the fiber (Roman & Gomes, 2018). Myofibers are 
composed of numerous myofibrils, which contain the smallest unit of contraction, known as the 
sarcomere (Frontera & Ochala, 2015). Within each sarcomere resides various contractile thick 
and thin filaments (and their associated proteins), or myosin and actin, respectively (Gash et al., 
2020; Mukund & Subramaniam, 2020). These alternating filaments are what give skeletal muscle 
its distinctive, striated appearance (Kuo & Ehrlich, 2015). Actin is covered by a protein, 
tropomyosin, which blocks the myosin binding sites on actin (Kuo & Ehrlich, 2015). An 
additional protein, troponin, can be found along actin and adjacent to tropomyosin. Composed of 
three subunits (I, T, and C), troponin I is responsible for blocking the interaction of actin and 
myosin, troponin T is responsible for the binding of calcium, and troponin C is responsible for 
binding to tropomyosin (Chen et al., 2015; Gash et al., 2020).   
Groups of these muscle fibers (or bundles) are referred to as fascicles, which then bundle 
together to form muscle tissue. Of note is that each layer is surrounded by a matrix of connective 
tissue (Lieber et al., 2017). Finally, the various muscle tissues give rise to the muscle itself. 
Cell Organelles 
Muscle fibers are surrounded by the sarcolemma, a plasma membrane. Contained within 
the sarcolemma are the sarcoplasmic reticulum, transverse (t) tubules, and mitochondria, all of 
which play a role during muscle contraction. More specifically, the sarcoplasmic reticulum stores 
and releases calcium while the t-tubules conduct the nerve signal along the length of the muscle 
fiber. The mitochondria form a network that is responsible for using oxygen, making ATP 
available to the cell (Frontera & Ochala, 2015).  
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Muscle Fibers Types 
 Not all skeletal muscle cells have the same properties. In fact, muscle cells differ in speed 
of contraction, metabolic processes (oxidative versus glycolytic), fatigue resistance, and handling 
of calcium ions (Ca2+) (Allen et al., 2008; Westerblad et al., 2010). Early classification of muscle 
fibers focused primarily on histochemical staining procedures: fibers containing larger amounts 
of myoglobin appeared redder (versus pale) and contracted more slowly than fibers that had 
smaller amounts of myoglobin (Zierath & Hawley, 2004). Current classification systems group 
muscle fibers according to their myosin heavy chain isoforms (Talbot & Maves, 2016). Under 
the current system, three fiber types exist: type I, type IIA, and type IIx (a fourth fiber, type IIb, 
exists in other mammals but is not present in humans) (Allen et al., 2008; Frontera & Ochala, 
2015). Type I fibers, known colloquially as slow-twitch fibers, are slower to contract and have 
greater oxidative capacities than fast type II fibers (fast-twitch fibers), due to their greater 
amounts of mitochondria (Westerblad et al., 2010). In contrast to type I fibers, type IIa fibers 
have intermediate contraction speeds, while type IIx fibers have the fastest contraction speeds 
(Allen et al., 2008). Fast isoforms more readily use adenosine triphosphate (ATP) (the biological 
currency of energy) compared to slow isoforms. Moreover, fast type II fibers fatigue more 
rapidly than slow type I fibers, due to the discrepancies in the mitochondrial content of the fiber 
(Allen et al., 2008; Frontera & Ochala, 2015; Herbison et al., 1982). Ca2+ pumps are also 
expressed differently in the sarcoplasmic reticulum of each fiber type. Type II fibers contain 
SERCA1, while type I fibers contain SERCAII. Of particular note is that fast fibers have a 
greater density of Ca2+ pumps compared to slow fibers (Allen et al., 2008; Westerblad et al., 
2010). Consequently, there is a larger, more pronounced spike in Ca2+ concentration in the type 
II fibers, which allows for faster and stronger muscle contractions compared to the type I fibers. 
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Skeletal Muscle Physiology 
 The process of muscle contraction is referred to in literature as excitation - contraction 
coupling (ECC) (Calderón et al., 2014). In this model, a nerve actional potential originates in the 
brain (specifically the motor cortex) and travels along the spinal cord down to the motor unit, 
which consists of an alpha (α) motor neuron and the muscle fibers it innervates (Potvin & 
Fuglevand, 2017). At the neuromuscular junction – where the axon terminal of the α motor 
neuron synapses with the muscle cell – acetylcholine is released into the synaptic cleft, where it 
activates sodium (Na+) channels along the sarcolemma (Allen et al., 2008; Kuo & Ehrlich, 2015).  
From here, the action potential is transmitted along the t-tubules to a protein called the 
dihydropyridine receptor (also known as the L-type Ca2+ channel) and then to another protein 
complex called the ryanodine receptors (also known as the SR Ca2+ channels), located in the 
sarcoplasmic reticulum (SR) (Calderón et al., 2014; Lanner et al., 2010). This causes the SR to 
release Ca2+, whereupon it binds to troponin C, causing tropomyosin to shift, exposing the 
myosin binding site of the actin filament (Frontera & Ochala, 2015; Mukund & Subramaniam, 
2020). ATP binds to myosin, allowing myosin to release actin (from a previous cross-bridge 
contraction), and subsequently hydrolyzes to form adenosine diphosphate (ADP) and inorganic 
phosphate (Pi) (Kuo & Ehrlich, 2015). Pi then detaches from the myosin, allowing a new cross-
bridge to form and creating a power stroke, ‘sliding’ actin past myosin, and ultimately causing 
muscle contraction (Frontera & Ochala, 2015; Geeves & Holmes, 1999). With ECC complete, 
ADP is released, allowing myosin to detach from troponin and return to its original position 
(Gash et al., 2020). Finally, the increased levels of Ca2+ are pumped back into the SR via 
SERCA, thereby causing tropomyosin to block the binding site on actin once again, and relaxing 
the muscle (Allen et al., 2008; Lanner et al., 2010).  
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Skeletal Muscle Energy Systems 
As described above, ATP is used during the process of muscle contraction. Indeed, it is the 
energy currency of muscle contraction, as well as other aspects of cell metabolism (e.g., protein 
assembly, biochemical transport, biosynthesis) (Hara & Kondo, 2015). Despite the continuous 
need for ATP, the body stores very little ATP within each cell (Bonora et al., 2012). 
Consequently, each muscle cell must constantly synthesize ATP, especially in cases of 
continuous contractions. This process, known as cellular respiration, can be divided into two 
basic pathways: aerobic (oxidative) and anaerobic (glycolytic) metabolism (Westerblad et al., 
2010). 
 If ATP is the energy currency of the cell, then glucose is the primary fuel (fats and amino 
acids are also utilized but at much lower frequencies) (Frontera & Ochala, 2015; Toyoda & 
Saitoh, 2015). In the first step of cellular respiration, glucose and nicotinamide adenine 
dinucleotide (NAD+) undergo glycolysis to form pyruvate and nicotinamide adenine dinucleotide 
(NADH), respectively. If oxygen is present, then the cell undergoes aerobic metabolism, and 
pyruvate is decarboxylated and attached to coenzyme A (CoA) to form acetyl-CoA (Toyoda & 
Saitoh, 2015). Acetyl-CoA subsequently enters the citric acid cycle (also known as the Krebs 
cycle), where it is continuously converted and reduced to produce the two cofactors NADH and 
flavin adenine dinucleotide (FADH2) (Bonora et al., 2012). From here, NADH and FADH2, as 
well as oxygen, undergo oxidative phosphorylation via the electron transport chain (ETC). 
Composed of a series of electron transfer complexes across the mitochondrial membrane, the 
ETC ultimately generates ATP (from ADP and Pi), water, and carbon dioxide (Bonora et al., 
2012; Toyoda & Saitoh, 2015).  
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 Meanwhile, if oxygen is not present, then the cell will undergo anaerobic metabolism. 
Once glycolysis occurs, pyruvate and NADH (from the citric acid cycle) are further reduced into 
lactate and NAD+. This temporarily maintains glycolysis by transferring hydrogen ions (H+) to 
pyruvate, thereby producing NAD+ (Bonora et al., 2012; Mukund & Subramaniam, 2020; 
Westerblad et al., 2010).  
  Incidentally, and of extreme importance, is the influence of exercise intensity on 
metabolism. Muscle fibers will use the small, existing reserves of ATP for short, intense bursts 
of physical activity lasting approximately one second. In contrast, high intensity isometric 
exercise lasting a few minutes, such as weightlifting, uses anaerobic glycolysis to produce ATP. 
Meanwhile, isotonic exercises of longer duration (minutes to hour), such as walking or running, 
use aerobic oxidation (Frontera & Ochala, 2015; Mukund & Subramaniam, 2020). Moreover, 
these pathways do not occur in an “all or none” fashion, but may be employed simultaneously at 
various points throughout a single session of exercise (Frontera & Ochala, 2015). Likewise, 
different sources of fuels, such as carbohydrates, fats, and proteins, may be used to produce ATP 
for one session of exercise (Frontera & Ochala, 2015).  
Oxygen and Carbon Dioxide Transport 
In order for the body to undergo cellular respiration, oxygen needs to be transported to 
the cells and carbon dioxide (CO2) removed. While the full, detailed understanding of internal 
and external respiration (not to be confused with cellular respiration) is beyond the scope of this 
paper, suffice it to say that oxygen makes its way into the body from the atmosphere through a 
series of concentration gradients and diffusion processes (both facilitated and unfacilitated) in the 
respiratory system (Law & Bukwirwa, 1999; Popel, 1989). Once in the alveoli of the lungs, 
oxygen diffuses across the alveolar-capillary membrane (ACM) to enter the bloodstream. The 
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heart then pumps this oxygenated blood to the various peripheral tissues of the body, to be used 
by the mitochondria for energy production (Treacher & Leach, 1998). Each muscle is supplied 
oxygen by a network of capillaries, the extent of which correspond to the muscle fiber’s 
metabolic requirements (Frontera & Ochala, 2015). While oxygen diffuses into the muscle, 
carbon dioxide, a waste product of cellular respiration, diffuses back into the venous 
bloodstream. From there, the carbon dioxide travels back to the heart, through the ACM, into the 
alveoli, and through the lungs to be exhaled back into the atmosphere (Yang & Liu, 2016).  
The rate at which the body consumes oxygen is also important: during periods of rest, 
oxygen delivery exceeds oxygen consumption, while during periods of exercise, oxygen 
consumption increases. In other words, oxygen consumption is dependent upon muscle fiber 
metabolic requirements (Frontera & Ochala, 2015). Equally important is that the body has no 
storage system for oxygen (Law & Burkwirwa, 1999; Treacher & Leach, 1998). If the body is 
unable to extract oxygen from the environment or cannot readily use oxygen available in the 
bloodstream, hypoxic hypoxia develops (as opposed to anemic or carbon monoxide hypoxia) 
(Popel, 1989). This lack of oxygen leads to anaerobic metabolism and production of lactate, 
resulting in muscular fatigue, hypoxemia, and tissue ischemia (Treacher & Leach, 1998).  
Skeletal Muscle Fatigue  
 As stated previously, muscle fatigue is a decline in performance related to muscle 
activity. However, other definitions have described fatigue as a decrease in contractile function; 
an inability to sustain a contraction; a decline in peak power; a decrease in muscle shortening 
force and velocity; and a delay in the rate of muscle relaxation (Allen et al., 2008; Enoka & 
Duchateau, 2008; Fitts, 2008; Westerblad et al., 2010). For the purposes of this paper, fatigue is 
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defined and examined in relation to the decline in the acceleration of the muscle fiber 
contraction. 
Fatigue is a result of various physiological factors and can occur throughout any step of 
muscle contraction. Fatigue may occur centrally or peripherally. In central fatigue, impairment 
occurs anywhere along the path from the motor cortex to the motor neuron. Muscles generate 
greater amounts of force by increasing either the number of motor neurons stimulated or the 
firing rate of the motor neuron; when central fatigue occurs, the nerve firing rate decreases while 
synaptic inhibition occurs, causing the motor neurons to become less responsive to excitation 
(Allen et al., 2008; Fuglevand, 1996; Martin et al., 2006). In contrast, peripheral fatigue 
transpires within the muscle itself (Westerblad et al., 2010). The force generated by each 
myosin-actin cross-bridge, as well as the number of cross-bridges formed, decreases during 
states of fatigue (Fitts, 2008). Failure of the SR to release Ca2+ also creates a reduction in the rate 
of ATP consumption, while myofibers have a reduction in sensitivity to Ca2+ (Allen et al., 2008; 
Westerblad et al., 2010).  
Although lactic acid and H+ due to anaerobic processes have been considered one of the 
primary factors of fatigue, recent research has indicated these factors play a minor role in causing 
skeletal muscle fatigue (Allen et al., 2008; Westerblad et al., 2010). For example, a study 
conducted by Lamb et al. found (1993) that a reduction in muscle force was due to the movement 
of water to the extracellular space, rather than by lactate. A 2005 study found that decreasing the 
rate of H+ accumulation in the cytosol of a frog muscle cell did not delay the onset of fatigue 
(Stary & Hogan, 2005). Instead, accumulated H+, along with an increase in Pi and ADP, appears 
to contribute to fatigue by inhibiting the SR Ca2+ pumps from binding with free floating Ca2+ 
(Kent-Braun et al., 2012; Allen et al., 2008). Other research has shown that an increase in H+ 
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may contribute more directly to fatigue by inhibiting the force per cross-bridge of the actin-
myosin cross-bridge, rather than by directly reducing the force output of the muscle fiber (Fitts, 
2008). 
Fatigue is additionally mediated by the production of reactive oxygen species (ROS). 
Multiple studies have shown that a decrease in ROS delays the onset of muscle fatigue 
(McKenna et al., 2006; Moopanar & Allen, 2006; Reid, 2001; Reid, 2008). Radical and non-
radical ROS are produced during oxygen reduction in the electron transport chain (Ray et al., 
2012). Interestingly, ROS can contribute to normal cell function, but an imbalance in prooxidants 
and antioxidants (i.e., oxidative stress) can lead to inflammatory response, cellular dysfunction, 
and diseases such as stroke, atherosclerosis, and diabetes (Forrester et al., 2018). While the site 
of ROS production in the muscle cell is still unclear, research has suggested it can occur in the 
mitochondria, SR, t-tubules, sarcolemma, and various enzymes (Powers et al., 2011). ROS 
production often increases during exercise, due to increased temperatures (Moopanar & Allen, 
2005). However, the exact mechanisms by which ROS cause fatigue is still under debate. 
Previous research has suggested production of ROS may lead to damage in actin, myosin, and 
tropomyosin, contribute to the decreased sensitivity of Ca2+ in the myofibers, and alter the 
structure of regulatory proteins (Fitts, 2008; Reid, 2001).  
Lack of oxygen supply has also been implicated in the onset of fatigue. In studies where 
blood flow has been occluded, muscle fatigue has developed more rapidly (Alfonsi et al., 1999; 
Russ & Kent-Braun, 2003). Similarly, a study that examined postural differences in subjects 
found that positions that restrict blood flow – thereby inducing greater intramuscular pressures 
and creating lower blood volumes – resulted in increased muscle fatigue (Tachi et al., 2004). 
This ultimately suggests that blood flow restriction, and therefore lack of oxygen, during muscle 
18 
contraction results in a greater energy cost. More specifically, when oxygen is no longer 
available to synthesize ATP, the body decreases the ATP demand (Lanza et al., 2006). 
Furthermore, different degrees of supplemental, inspired oxygen have resulted in a delayed onset 
of fatigue in recreationally active individuals and athletes (Amann et al., 2006; Hogan et al., 
1999). Clearly, while oxygen is not the only factor that contributes to muscle performance, there 
is a critical level of tissue oxygenation. If this level is not met, fatigue may be exacerbated.  
Mechanomyography 
Multiple methods have been used to study muscle fatigue, including electromyography, 
transcranial magnetic stimulation, and near infrared spectroscopy (Taelman et al., 2011; Todd & 
Gandevia, 2003; Schillings et al., 2003). In more recent years, however, mechanomyography has 
been proposed as an alternative method due to the methodological limitations (i.e., cost and 
technical factors) of current practices (Woodward et al., 2019).  
Simply put, mechanomyography (MMG) is the study of skin surface displacement due to 
a contracting muscle. The mechanomyogram measures the compound mechanical signal 
generated by the motor units (Shinohara & Søgaard, 2006). However, the MMG measurement is 
a reflection of the number of motor units recruited, rather than the motor unit firing rate 
(Ebersole & Malek, 2008). As the number of recruited motor units increases, the muscle 
generates a greater force. This causes a greater displacement of the skin surface and is recorded 
as a change in amplitude on the MMG (Shinoara & Søgaard, 2006). On the other hand, as a 
muscle fatigues, twitch height and the number of firing motor units decreases. This subsequently 
causes both a decrease in the displacement of the skin surface and the amplitude of the MMG 
(Shinohara & Søgaard, 2006).  
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Preliminary studies have examined whether MMG is an accurate method to assess muscle 
endurance. For instance, Willingham & McCully (2017) found that acceleration correlated with 
muscle torque with the use of MMG via an accelerometer. A second study conducted by 
McCully et al., (2018) indicated use of MMG via an accelerometer accurately evaluated muscle 
endurance in the lower back erector muscles. MMG has also been found to correlate with 
electromyography results, as well as measurements of muscle force (Akataki et al., 2001; 
Ebersole & Malek, 2008; Gobbo et al., 2006; Orizio et al., 1999). 
Despite these promising results, MMG has not been used to examine conditions of blood 
flow. As discussed previously, muscle fatigue is exacerbated when oxygen is unavailable to 
conduct aerobic respiration. As muscle continues to fatigue, muscle fiber acceleration decreases. 
Theoretically, MMG should detect the decline in acceleration as a decrease in amplitude. Given 
these points, the current study sought to determine whether MMG is sensitive enough to 
distinguish between different states of blood flow, thereby detecting functional changes within 
the muscle. 
CHAPTER III 
Methodology 
The proposed research design was a quantitative, interventional study. Participants were 
enrolled from August 2019 to December 2019. Participants underwent a series of tests that 
measured the acceleration of the dominant wrist extensor (extensor carpi radialis muscle) and the 
dominant leg dorsiflexor (tibialis anterior muscle). Muscle acceleration was assessed with 
complete blood flow (i.e., no occlusion) and full occlusion of blood flow for each muscle. This 
study was conducted with full review and approval by the Georgia State University Institutional 
Review Board.  
Participants  
 Ten participants (female = 2, male =8) were recruited voluntarily via word of mouth and 
flyers posted around Georgia State University. Each participant provided written informed 
consent and completed a health history form (Appendix A) before participating in the study. All 
participants were over the age of 18 and were recreational athletes that engaged in high levels of 
exercise. Participants at risk for cardiovascular and musculoskeletal injury according to the 
American College of Sports Medicine Guidelines (Thompson et al., 2009) were excluded from 
the study. Pregnant women and children were also excluded from the study.  
Experimental Procedures 
 Each participant performed a muscle acceleration test twice each for the ankle dorsiflexor 
and the wrist extensor. In one trial, blood flow was occluded using a commercially available 
tourniquet (Combat Application Tourniquet, North American Rescue: Greer, SC). Trial order 
was counterbalanced with half the participants performing the tourniquet trial first and the other 
half of participants performing the tourniquet trial second in order to counteract any testing order 
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bias. Participants were allowed a ten minute break between trials in order to allow the muscle to 
rest and recover.  
During the ankle dorsiflexor muscle test, the participant lay supine with the dominant 
ankle secured to a metal base place via an orthopedic brace and Velcro straps. During the wrist 
extensor muscle test, the participant sat upright with the dominant arm extended upon a table. 
The wrist was secured to a metal brace via an orthopedic brace and Velcro straps. A triaxial 
accelerometer (Axivity A3: Axivity, Newcastle, UK) was placed on the belly of the muscle, 1/3 
of the muscle length from the origin to the insertion sites for both the ankle dorsiflexor and wrist 
extensor muscle. In order to avoid aliasing of the twitch signal, the accelerometer began 
recording at 800Hz immediately after disconnection. Uni-PatchTM S series electrodes (Covidien, 
Mansfield, MA) were placed superior and inferior to the accelerometer. A clinical electrotherapy 
stimulator (Vectra Genisys, Chattanooga®, Vista CA), was programmed to stimulate the muscle 
at 2, 4, and 6 Hz for 3 minutes each at 60mA. 
Tourniquet Procedure  
Once each muscle was secured properly, a tourniquet was tightened across the brachial 
artery and the popliteal artery in order to fully occlude blood flow in the wrist extensor and ankle 
dorsiflexor, respectively. Blood flow was determined to be occluded once the researcher could 
no longer palpate the radial arterial pulse or the dorsalis pedis arterial pulse. Each muscle was 
then stimulated for 2, 4, and 6 Hz for 3 minutes each at 60millimaps.  
Data Analysis 
 After completion of each trial, recording on the accelerometer was stopped and the data 
was downloaded to a secured, password protected computer. Data was deidentified before 
analyses. Acceleration data were stored in a .CSV time series file for analyses. A program 
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written in Python, Jupyterlab Version 0.35.3, was used to identify the peak and trough muscle 
accelerations for each participant using the following formula: 
Total Acceleration = √𝑋𝐴𝑐𝑐𝑒𝑙𝑒𝑟𝑎𝑡𝑖𝑜𝑛2 + 𝑌𝐴𝑐𝑐𝑒𝑙𝑒𝑟𝑎𝑡𝑖𝑜𝑛2 + 𝑍𝐴𝑐𝑐𝑒𝑙𝑒𝑟𝑎𝑡𝑖𝑜𝑛2 
These accelerations were then saved to a new .CSV file for further comparisons. Minimum 
twitch height was subtracted from the peak height to ascertain the individual peak to peak height. 
Each subject’s peak to peak analysis was normalized to the peak acceleration for each blood flow 
trial. This was done for each stimulation frequency in order to perform a comparison between 
trials. A repeated measures analysis of variance (ANOVA) was performed with stimulation 
frequency (2Hz, 4Hz, 6Hz) used as the within factor and trial (normal blood flow and full 
occlusion) as the between factor. A separate ANOVA was performed using trial order as the 
between factor to test whether the ordering of the trials affected the outcome. If a difference was 
detected, a main effects test with Bonferroni correction was performed in order to determine 
when the differences occurred.  
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CHAPTER IV 
Results 
The purpose of this study was to determine whether accelerometer based 
mechanomyography could detect functional changes in the muscle (i.e., level of muscle twitch 
height) by simulating different conditions of blood flow to the muscle. This research study 
explored patterns of twitch height among different stimulation frequencies in the dominant ankle 
dorsiflexor and dominant wrist extensor muscles. The results are presented in this chapter. 
Descriptive statistical analyses are included.  
Research Hypotheses 
1. Poorly perfused muscles will have decreased muscle twitch accelerations compared to 
adequately perfused muscles.  
2. Decreases in poorly perfused muscle twitch accelerations will appear at lower stimulation 
frequencies compared to adequately perfused muscles.  
Descriptive Data  
 Age of participants ranged from 23 to 46 years (M = 33.6, SD = 8.42). Height, weight, 
and body mass index (BMI) means and standard deviations are presented in Table 1.  
Table 1.  Height, weight, Body Mass Index (BMI), and sex of participants (n = 10) 
               Mean or %        Standard Dev  
Height (cm)    178.56    11. 67 
Weight (kg)    83.5    20.06 
BMI     25.80    3.34 
Female    20%    - 
Male     80%    - 
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Ankle Dorsiflexor 
 Statistical analyses indicated muscle twitch height in the occluded blood flow trial was 
decreased by 0.515 ± 0.198g compared to the normal blood flow trial (p = 0.018). Specifically, 
the twitch height in the occluded blood flow trial was significantly lower than the twitch height 
in the normal blood flow trial throughout the 2Hz, 4Hz, and 6Hz stimulation frequencies (Figure 
1).  
 
 
 
Figure 1. Comparison of Mean Muscle Twitch Accelerations in Non-Occlusion vs. Full 
Occlusion Trials in the Ankle Dorsiflexor. 
 
 
Wrist Extensor 
 Statistical analyses revealed muscle twitch height in the occluded blood flow trial was 
decreased by 0.944 ± 0.188g compared to the normal blood flow trial (p < 0.001). Occluded 
(*) Denotes 
significant effect 
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blood flow trial muscle twitch height was significantly lower than the twitch height in the normal 
blood flow trial throughout the 4Hz and 6Hz stimulation frequencies (Figure 2).  
 
 
 
Figure 2. Comparison of Mean Muscle Twitch Accelerations in Non-Occlusion vs. Full 
Occlusion Trials in the Wrist Extensor.  
 
 
Comparison between Muscle Groups.  
Statistical analyses indicated that compared to the muscle twitch accelerations in the wrist 
extensor normal blood flow trial, the muscle twitch accelerations in the ankle dorsiflexor were 
decreased by 1.173± 0.242g (p < 0.001). However, after normalizing the data, differences were 
eliminated between the ankle dorsiflexor and wrist extensor muscle twitch accelerations (p = 
0.401).  
(*) Denotes 
significant effect 
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 Statistical analyses indicated that compared to the muscle twitch accelerations in the wrist 
extensor occluded blood flow trial, the muscle twitch accelerations in the wrist extensor were 
decreased by 0.744 ± 0.130g (p < 0.001). However, differences between the ankle dorsiflexor 
and wrist extensor muscle twitch accelerations were no longer significant after the 4Hz 
stimulation frequency.  
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CHAPTER V 
Discussion 
As mentioned previously, the focus of this study was to ascertain whether accelerometer 
based muscle mechanomyography could discriminate between different levels of muscle twitch 
accelerations, and therefore detect functional changes within the muscle. Overall, poorly 
perfused muscles (i.e., muscles with occluded blood flow) had decreased muscle twitch 
accelerations compared to muscles with normal perfusion (i.e., muscles with full blood flow). 
This indicates that accelerometer based muscle mechanomyography is sensitive enough to detect 
changes in blood flow. 
Prior researched has found that occluding blood flow has enhanced fatigue during 
voluntary and stimulated contractions (Broxterman et al., 2015; Cole & Brown, 2000; Royce, 
1958). In a 2000 study conducted by Cole & Brown, significant fatigue occurred after five 
minutes of contractions, even when the blood flow was only partially occluded. In the current 
study, application of a tourniquet to occlude blood flow above the elbow resulted in significantly 
lower muscle twitch heights compared to normal blood flow, indicating greater muscle fatigue. 
In contrast, application of the tourniquet to occlude blood flow above the knee resulted in overall 
decreases of muscle twitch heights but failed to enhance true fatigue. These discrepancies could 
be a result of the different levels of stimulation: in the current study, relatively low levels of 
stimulation were used (60mA), compared to the high levels used (200-300mA) in Cole & Brown 
(2000).  
Previous research has also found that different patterns of muscle twitch heights occur 
between different muscles while using this technique. In one recent study, Willingham & 
McCully (2017) found significantly greater rates of fatigue in the forearm muscle when it was 
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compared against the calf muscle. And in two further studies, differences in muscle fatigue were 
found among the erector spinae, trapezius muscles, vastus lateralis, and wrist flexors, with the 
erector spinae and trapezius muscles having significantly greater amounts of fatigue compared to 
the vastus lateralis and wrist flexors (McCully et al., 2019; McCully et al., 2018). In the current 
study, differences in muscle twitch height were found between the ankle dorsiflexor and wrist 
extensor during the occluded blood flow trial. Muscle twitch height in the ankle dorsiflexor was 
significantly lower across all stimulation frequencies, while muscle twitch height in the wrist 
extensor was significantly decreased only during the 4Hz and 6Hz stimulation frequencies. 
Findings also indicated ankle dorsiflexor twitch height was lower than wrist extensor twitch 
height during the normal blood flow trial. Yet when data were normalized, these differences 
were no longer significant. These discrepancies may be attributed to the physiological makeup of 
each muscle group. The ankle dorsiflexor is composed of a greater number of type I and type IIA 
muscle fibers, while the wrist extensor is composed of a greater number of type IIx muscle fibers 
(Green et al., 2015; Hata et al., 2019; Rodrigues et al., 1994). As mentioned previously, type I 
and type IIA fibers have higher aerobic capacities, while type IIx fibers have higher anaerobic 
capacities (Herbison et al., 1982; Talbot & Maves, 2016). By occluding blood flow, the ankle 
dorsiflexor may have depleted its aerobic and anerobic energy stores faster than the wrist 
extensor.  
Significant Limitations 
Significant limitations were considered in the current study. First, this study used a small, 
limited sample size comprised of mostly males (80%). Second, because we intentionally sought 
to include recreationally athletic individuals, and despite our efforts to simulate clinical 
conditions in participants, the observed results of the study may not generalize to clinically 
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relevant populations. Third, occlusion of blood flow was subjectively determined by palpation; 
intra-rater and inter-rate reliability were not examined in this study.  
Recommendations for Future Research 
 Future research in the area of accelerometer based mechanomyography should be 
conducted. Mechanomyography is cost effective and can be used on sedated or unresponsive 
patients. A controlled, randomized in vivo study should be conducted on clinically relevant 
populations. In addition, other data parameters, such as muscle contraction time frame, or time to 
peak muscle acceleration during stimulation, should be considered. Future studies should also 
consider using an objective measure, such as a doppler ultrasound, to determine when blood flow 
is fully occluded. Furthermore, analyses should examine whether muscle twitch height or other 
similar parameters differ between males and females or among different age groups.  
Conclusion 
Current diagnostic procedures for muscle fatigue and atrophy are limited. This study 
serves to highlight a new, alternative procedure for diagnosis. Outcomes of this study indicate 
accelerometer measured muscle fatigue is capable of detecting differences between normal and 
occluded blood flow states. Future research should be conducted on accelerometer based 
mechanomyography in order to ameliorate, treat, and prevent muscle weakness. Future research 
should additionally ascertain whether differences exist in morbidity, morality, and quality of life 
when patients receive no intervention, early intervention, and late intervention for muscle 
weakness.  
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APPENDIX A 
Applied Physiology Laboratory 
Department of Respiratory Therapy 
Georgia State University 
 
Health History 
 
All information given is personal and confidential.  The information will enable us to better 
understand you and your health and fitness habits. 
 
Name__________________________________________________Date________________ 
 
Address______________________________________________ 
Home Phone___________________ 
 
City/State____________________________________________ 
Zip Code_______________________ 
 
Email_________________________________________________________________________ 
 
Occupation___________________________________________ 
Other Phone___________________ 
 
Birth 
Date________________Gender________Height________Weight_________Ethnicity_______ 
***************************************************************************** 
I. Signs and Symptoms 
****************************************************************************** 
Have you ever experienced any of the following: 
(please circle yes or no) 
47 
yes   no 1. Pain, discomfort, tightness or numbness in the chest, neck, jaw or arms. 
 
yes   no 2. Shortness of breath at rest or with mild exertion. 
 
yes   no 3. Dizziness or fainting. 
 
yes   no 4. Difficult, labored or painful breathing during the day or at night. 
 
yes   no 5. Ankle swelling. 
 
yes   no 6. Rapid pulse or heart rate. 
 
yes   no 7. Intermittent cramping. 
 
yes   no 8. Known heart murmur. 
 
yes   no 9. Unusual shortness of breath or fatigue with usual activities. 
 
If you answered yes to any of the above— 
How often do you experience the symptom?_________________________________________ 
 
Have you ever discussed the symptom with a doctor?__________________________________ 
 
Explain the symptom in more detail:_______________________________________________ 
 
____________________________________________________________________________ 
****************************************************************************** 
II. Major Risk Factors 
****************************************************************************** 
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yes   no 1. Do you have a body mass index  30 or a waist girth 100 cm? 
 
yes   no 2. Have you had a fasting glucose of  110 mg/dl confirmed by measurements on  
   at least 2 separate occasions. 
 
yes   no 3. Has your father or brother experienced a heart attack before the age of 55?  Or 
has your mother or sister experienced a heart attack before the age of 65? 
 
yes   no 4. Do you currently smoke or quit within the past 6 months? 
 
yes   no 5. Has your doctor ever told you that you have high blood pressure? 
 
yes   no 6. Do you have high cholesterol? 
  Total cholesterol:_____________HDL:__________Date tested:_____________ 
 
yes   no 7. Do you have a sedentary lifestyle? (sitting most of the day in your job with no 
regular   physical activity) 
 
****************************************************************************** 
III. Medical Diagnoses 
****************************************************************************** 
 
Have you ever had any of the following?  Circle all that apply: 
 
heart attack       angioplasty             heart surgery       coronary artery 
disease 
 
angina        hypertension            heart murmur       heart clicks 
 
49 
asthma                   emphysema            bronchitis       stroke 
 
anemia                   phlebitis             emboli        cancer 
 
osteoporosis       emotional disorders          eating disorders        
 
Any special problems not listed 
above:___________________________________________________ 
 
If any of the above are circled, please give details and 
explain:________________________________ 
 
 
 
 
 
 
 
****************************************************************************** 
IV. General 
****************************************************************************** 
 
yes   no 1. Are you pregnant? 
 
yes   no 2. Do you have arthritis or any bone or joint problem?   
If yes, please explain:_______________________________________________ 
 
  
 ________________________________________________________________ 
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yes   no 3. Do you currently exercise?   
  If yes, how long have you been exercising?______________________________ 
 
    What do you do and how often?_______________________________________ 
 
yes   no 4. Are you taking any medication, vitamins or supplements? 
 Name them and their dosage (list both prescribed and over-the-counter medications) 
 Drug name and dosage  /  purpose of drug  /  prescribed or over-the-counter 
 
  
 ________________________________________________________________ 
 
  
 ________________________________________________________________ 
****************************************************************************** 
 
My signature certifies that all of the above is true, to the best of my knowledge. 
 
 
Signature:__________________________________________Date:_______________________ 
 
****************************************************************************** 
STAFF USE ONLY 
****************************************************************************** 
 
Comments:____________________________________________________________________         
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Stratification(circle one): Low Risk  Moderate Risk  High Risk         
 
Resting blood pressure:__________________Resting heart rate:__________________ 
 
yes   no Do meds affect BP or HR? 
 
Date:_______________________Initials:_______________ 
 
